Biocon Biologics
Brian Goode is a seasoned pharmaceutical sales professional with extensive experience in oncology and biologics. Currently serving as a Senior Field Specialist in Biosimilars at Biocon Biologics, Brian previously held the position of Senior Field Specialist in Oncology at Viatris, where responsibilities included engaging key decision-makers in South Carolina's oncology landscape. Brian's career also encompasses roles at Theratechnologies, Amgen, Eisai US, and Merck, with a strong track record in product launches and achieving top performance accolades, including National Rookie of the Year in 2021 and consistent rankings among the top sales representatives in various organizations. Brian holds a Bachelor of Arts in Economics from the University of North Carolina at Chapel Hill.
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics